2023
Systematic review of inferior vena cava atresia
Saab K, Brahmandam A, Brackett A, Desai M, Dardik A, Guzman R, Chaar C. Systematic review of inferior vena cava atresia. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2023, 11: 1253-1264. PMID: 37453547, DOI: 10.1016/j.jvsv.2023.07.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsDeep vein thrombosisIVC atresiaCongenital anomaliesLeg painMost patientsDevelopment of DVTSystematic reviewAcceptable mid-term resultsInferior vena cava atresiaEndovascular surgical interventionsMortality of patientsOutcomes of patientsMid-term resultsRare venous anomalyTerms of patencyVein thrombosisSymptomatic reliefVenous anomaliesIliac veinInferior venaSurgical interventionMean ageTreatment groupsPatientsAtresia
2021
Alternate accesses for transcatheter aortic valve replacement: A network meta‐analysis
Hameed I, Oakley CT, Hameed NUF, Ahmed A, Naeem N, Singh S, Rizwana K, Brackett A, Forrest JK, Kaple R, Mangi A, Salemi A, Geirsson A, Gaudino M, Vallabhajosyula P. Alternate accesses for transcatheter aortic valve replacement: A network meta‐analysis. Journal Of Cardiac Surgery 2021, 36: 4308-4319. PMID: 34494307, DOI: 10.1111/jocs.15961.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementAortic valve replacementTF accessValve replacementHigher long-term mortalityLong-term strokeSuperior postoperative outcomesLong-term mortalityRandom-effects networkComprehensive literature searchDifferent treatment groupsPostoperative outcomesTransfemoral accessRandomized trialsTA accessTranscarotidTreatment groupsTransapicalLiterature searchTC accessCombination of TFSignificant differencesStrokeProbability rankMortality
2020
Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis
Klemen ND, Feingold PL, Hashimoto B, Wang M, Kleyman S, Brackett A, Gross CP, Pei KY. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. The Lancet Haematology 2020, 7: e583-e593. PMID: 32735837, DOI: 10.1016/s2352-3026(20)30211-8.Peer-Reviewed Original ResearchConceptsVenous thromboembolism preventionFatal pulmonary embolismPulmonary embolismVenous thromboembolismThromboembolism preventionMajor bleedingRisk ratioMortality riskTreatment groupsControl groupSystematic reviewLess major bleedingMedian risk ratioMore pulmonary embolismDe-escalation trialsVenous thromboembolism riskStudy of patientsActive control agentWeb of ScienceAntiplatelet therapyEligible RCTsPrimary endpointSecondary endpointsComposite endpointOverall mortality